Untested COVID-19 vaccine, Sputnik V, begins 40,000-person trial next week
Companies, agencies, institutions, etc
the Russian Direct Investment Fund
COVID-19
ReadingRussia
Ministry of Health
ScienceInsider
The World Health Organization
AP
Clinicaltrials.gov
WHO
the Ars Orbital Transmission
CNMN Collection
WIRED Media Group
Condé Nast
People
Beth Mole
Sputnik V
Vladimir Putin
registered).Beyond Sputnik V
Ars
Groups
Russian
COVID-19
Physical locations
No matching tags
Places
No matching tags
Locations
Russia
Events
No matching tags
Summary
After hastily granting approval last week for a COVID-19 vaccine that has yet to enter rigorous clinical trials, Russia has now announced plans to give the vaccine to more than 40,000 volunteers in a trial that starts next week.The “previously planned post-registration” injections are part of a “randomized, double-blind, placebo-controlled multicenter clinical study” of the vaccine, dubbed Sputnik V, according to an August 20 press release from the Russian Direct Investment Fund, which has financially backed the development of the vaccine. The more than 40,000 people for the trial will be recruited from more than 45 medical centers, the press release added.On August 11, Russian President Vladimir Putin announced that Sputnik V had won regulatory approval, making it the first COVID-19 vaccine in the world to achieve domestic approval.
As said here by Beth Mole